Latest episodes

TSE Straight Road – IR Navigator
Earnings Radio & Investor’s IR Insights.
Easy-to-understand breakdowns of listed companies’ IR materials and Japanese stock earnings reports.
Your watcher of Japan’s corporate earnings.
Behind the scenes of listed companies.
Untold stories of stocks and financial results.
A money-viewing window into the market.
Discover the secrets of Japanese stocks in just 8–25 minutes.
Understandable Financial Statements 101 – Learn how to read a company’s report card.
Enjoy your youth by reaching FIRE through Japanese NISA, DC, and iDeCo.
Close your eyes and learn by ear — the blissful time for investment study.
Olympus Corporation, established on October 12, 1919, initially aimed to domesticate microscope production in Japan. Today, headquartered in Tokyo, it has successfully transformed into a leading global MedTech company. Driven by its core purpose of "Making people’s lives healthier, safer and more fulfilling," Olympus is dedicated to advancing medical standards and improving patient outcomes.
Since developing the world's first practical gastrocamera in 1950, the company has become a dominant force in the medical field, commanding approximately a 70% global market share in gastrointestinal endoscopes. Operating primarily through its Endoscopic Solutions and Therapeutic Solutions divisions, Olympus provides innovative medical devices centered on "Early Detection" and "Minimally Invasive Therapy". These technologies help improve patients' quality of life while reducing overall healthcare costs. With over 29,000 employees globally across 40 countries or regions, Olympus continues to leverage its advanced technologies to shape the future of healthcare.
The audio and written content provided in this podcast are for informational and general reference purposes only and are intended to introduce publicly available information and basic business conditions of major listed companies in Japan. They do not constitute investment advice, investment recommendations, investment solicitations, or a basis for any investment decision. Investing involves risks, and all investment decisions should be made at the listener’s own discretion and responsibility.

※1–2 new episodes will be released weekly.
If there’s a publicly listed company you’re interested in, we’ll prioritize making an episode about it, so please let us know in the comments.
Listening in your apps
- Spotify
https://open.spotify.com/show/6PjSIY5ZFFUhLgQDeXbtA7?si=d30779580fab43a1 - Apple
https://podcasts.apple.com/jp/podcast/japan-stock-podcast/id1847632150 - Amazon
https://music.amazon.co.jp/podcasts/e2fc8378-ed3b-49e5-ae37-75ec79afdc4e/japan-stock-podcast - Youtube
https://youtube.com/playlist?list=PLj2ef7-y4WVQtXmzMG3OVt8KG_8mOw4VR&si=LrLW5jgUZyYdcgLH - XiaoYuZhou(小宇宙)
https://www.xiaoyuzhoufm.com/podcast/68fa2ff7083a71a4ebf1d925
This podcast is for informational purposes only and does not constitute investment advice. Listeners should make investment decisions at their own discretion and risk.

Comments